Mandelia Ashish — SEC Form 4 filings
SEC reporting owner CIK 1782805. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-06.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-17 to 2026-01-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 5 filings — 19,593 shares, $33,770 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 40.
- Largest priced transaction: sale of 5,025 shares @ $2.71 ($13,618) in Mersana Therapeutics, Inc., filed 2024-01-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mersana Therapeutics, Inc. (MRSN) | VP, Chief Accounting Officer | 7 | — | 6 legs · 19,593 sh · $33,770 | 40 |
Form 4 filings — Mandelia Ashish
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-06 | 4 | Mersana Therapeutics, Inc. (MRSN) | Code (U): 2,300 · Disposition to issuer (D): 1,687 (derivative) · Disposition to issuer (D): 1,312 (derivative) · Disposition to issuer (D): 2,870 (derivative) · Disposition to issuer (D): 555 (derivative) · Disposition to issuer (D): 44 (derivative) · +12 more | EDGAR |
| 2025-01-17 | 4 | Mersana Therapeutics, Inc. (MRSN) | Option exercise (M): 4,519 @ $0 · Option exercise (M): 4,166 @ $0 · Sale (S): 3,554 @ $0.58 · Option exercise (M): 4,519 (derivative) @ $0 · Option exercise (M): 4,166 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0 · +1 more | EDGAR |
| 2025-01-16 | 4 | Mersana Therapeutics, Inc. (MRSN) | Option exercise (M): 4,783 @ $0 · Sale (S): 1,791 @ $0.63 · Option exercise (M): 4,783 (derivative) @ $0 | EDGAR |
| 2025-01-15 | 4 | Mersana Therapeutics, Inc. (MRSN) | Option exercise (M): 2,646 @ $0 · Sale (S): 1,007 @ $0.66 · Option exercise (M): 2,646 (derivative) @ $0 | EDGAR |
| 2024-10-07 | 4 | Mersana Therapeutics, Inc. (MRSN) | Option exercise (M): 30,000 @ $0 · Sale (S): 4,855 @ $2 · Sale (S): 3,361 @ $1.96 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4/A | Mersana Therapeutics, Inc. (MRSN) | Holdings only — no transactions reported | EDGAR |
| 2024-01-17 | 4 | Mersana Therapeutics, Inc. (MRSN) | Option exercise (M): 2,645 @ $0 · Option exercise (M): 4,783 @ $0 · Option exercise (M): 4,519 @ $0 · Option exercise (M): 833 @ $0 · Sale (S): 5,025 @ $2.71 · Option exercise (M): 2,645 (derivative) @ $0 · +5 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1782805 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →